8-K - Kiniksa Pharmaceuticals International, plc (0001730430) (Filer)
Published . Updated .
8-K - Kiniksa Pharmaceuticals International filed an 8-K with the SEC on Oct 27 (a notice of a material company event).
Directly affected
- KNSA Kiniksa Pharmaceuticals International-8.0% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- LLY Eli Lilly and+12.6% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- JNJ Johnson & Johnson-0.2% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- PFE Pfizer+8.1% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- MRK Merck-2.9% 14d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| KNSA | +14.09% | +10.72% | base | after close | after close | after close | after close |
| XLV | +0.28% | +1.14% | base | after close | after close | after close | after close |
| XBI | +1.83% | +0.75% | base | after close | after close | after close | after close |
| LLY | +0.43% | +2.14% | base | after close | after close | after close | after close |
| JNJ | -2.60% | +0.52% | base | after close | after close | after close | after close |
| PFE | +1.17% | +2.11% | base | after close | after close | after close | after close |
| MRK | +5.40% | +4.65% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-10-27 AccNo: 0001730430-26-000037 Size: 397 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Price since this story was published: Kiniksa Pharmaceuticals International (KNSA)
| Company | When | Move | Status |
|---|---|---|---|
| Johnson & Johnson (JNJ) | three days earlier | +0.52% | final price |
| Johnson & Johnson (JNJ) | five days earlier | -2.60% | final price |
| Kiniksa Pharmaceuticals International (KNSA) | three days earlier | +10.72% | final price |
| Kiniksa Pharmaceuticals International (KNSA) | five days earlier | +14.09% | final price |
| Eli Lilly (LLY) | three days earlier | +2.14% | final price |
| Eli Lilly (LLY) | five days earlier | +0.43% | final price |
| Merck (MRK) | three days earlier | +4.65% | final price |
| Merck (MRK) | five days earlier | +5.40% | final price |
| Pfizer (PFE) | three days earlier | +2.11% | final price |
| Pfizer (PFE) | five days earlier | +1.17% | final price |
| Spdr Series Trust (XBI) | three days earlier | +0.75% | final price |
| Spdr Series Trust (XBI) | five days earlier | +1.83% | final price |
| Select Sector Spdr Tr (XLV) | three days earlier | +1.14% | final price |
| Select Sector Spdr Tr (XLV) | five days earlier | +0.28% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 53 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 32 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 49 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 53 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 53 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 67 days before publication. Filed 8 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 31 Jul 2026. That is 88 days before publication. Filed 22 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 33 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 69 days before publication. Filed 9 Sep 2026. View the filing.
- Donald J Trump, an executive branch official, sold Merck (MRK), worth $250,001 - $500,000 on 31 Jul 2026. That is 88 days before publication. Filed 22 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Kiniksa Pharmaceuticals International (KNSA)
Companies carried with this story
- KNSA Kiniksa Pharmaceuticals International
For “8-K - Kiniksa Pharmaceuticals International, plc (0001730430) (Filer),” Kiniksa Pharmaceuticals International (KNSA) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> KNSA
- XLV Select Sector Spdr Tr
In “8-K - Kiniksa Pharmaceuticals International, plc (0001730430) (Filer),” Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence. Reason on file: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story
- XBI Spdr Series Trust
For “8-K - Kiniksa Pharmaceuticals International, plc (0001730430) (Filer),” Spdr Series Trust (XBI) is linked, with no stored direction, medium confidence. Reason on file: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story
- LLY Eli Lilly
In “8-K - Kiniksa Pharmaceuticals International, plc (0001730430) (Filer),” Eli Lilly (LLY) is linked, with no stored direction, medium confidence. Reason on file: Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story
- JNJ Johnson & Johnson
For “8-K - Kiniksa Pharmaceuticals International, plc (0001730430) (Filer),” Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence. Reason on file: Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story
- PFE Pfizer
In “8-K - Kiniksa Pharmaceuticals International, plc (0001730430) (Filer),” Pfizer (PFE) is linked, with no stored direction, medium confidence. Reason on file: Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story
- MRK Merck
For “8-K - Kiniksa Pharmaceuticals International, plc (0001730430) (Filer),” Merck (MRK) is linked, with no stored direction, medium confidence. Reason on file: Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story
Kiniksa Pharmaceuticals International (KNSA)
Kiniksa Pharmaceuticals International (KNSA) is the company in “8-K - Kiniksa Pharmaceuticals International, plc (0001730430) (Filer),” the 27 Oct 2026 this story story.
The link for Kiniksa Pharmaceuticals International (KNSA) is this: SEC 8-K filing -> direct issuer disclosure -> KNSA
A second company, Select Sector Spdr Tr (XLV), is listed for a different reason: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story
Price levels for Kiniksa Pharmaceuticals International (KNSA)
KNSA traded between 70.70 and 84.06 across 20 sessions. The latest close on file is 72.95. XBI traded between 152.63 and 158.97 across 2 sessions. The latest close on file is 154.01. XLV traded between 166.19 and 168.74 across 2 sessions. The latest close on file is 167.68.
How strong the case is around Kiniksa Pharmaceuticals International (KNSA)
46 out of 100
“8-K - Kiniksa Pharmaceuticals International, plc (0001730430) (Filer)” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.